AprilBio

397030 · KOSDAQ · Health Care · SMALL CAP

Securities issuance results (voluntary)

AprilBio completed a third-party-placement rights offering of 3,608,595 voting convertible preferred shares for US$105M, paid in on 2026-07-23; the new shares will not be listed and will be held in escrow with the Korea Securities Depository for one year.

Capital raise(Securities issuance results (voluntary))· FILED 2026-07-23· RCEPT 20260723900324

What happened

Securities Issuance Results (Voluntary Disclosure) 1. Type of securities: Registered convertible preferred stock with voting rights 2. Method of issuance: Third-party placement rights offering 3. Issuance details: - Planned number of shares to be issued: 3,608,595 - Planned issuance amount (KRW): 154,999,981,035 - Initial board resolution date for the issuance decision: 2026-06-24 - Actual number of shares issued: 3,608,595 - Actual issuance amount (KRW): 154,999,981,035 - Payment date: 2026-07-23 4. Whether listing is planned: No 5. Other matters for investment reference: - The new shares issued under this rights offering will be held in custody with the Korea Securities Depository for one year from the date of circulation (electronic registration date). Related disclosures: 2026-06-25 Rights offering decision (third-party placement - convertible preferred stock with voting rights); 2026-07-23 Contract concerning change of management control, etc.

Filed2026-07-23, Securities issuance results (voluntary)
SourceDART rcept 20260723900324 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-23 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).